rs1979370

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_023036.6(DNAI2):​c.1672G>A​(p.Ala558Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.881 in 1,610,478 control chromosomes in the GnomAD database, including 631,593 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 48710 hom., cov: 27)
Exomes 𝑓: 0.89 ( 582883 hom. )

Consequence

DNAI2
NM_023036.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -2.17
Variant links:
Genes affected
DNAI2 (HGNC:18744): (dynein axonemal intermediate chain 2) The protein encoded by this gene belongs to the dynein intermediate chain family, and is part of the dynein complex of respiratory cilia and sperm flagella. Mutations in this gene are associated with primary ciliary dyskinesia type 9. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.3897465E-7).
BP6
Variant 17-74312180-G-A is Benign according to our data. Variant chr17-74312180-G-A is described in ClinVar as [Benign]. Clinvar id is 163171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-74312180-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.899 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DNAI2NM_023036.6 linkuse as main transcriptc.1672G>A p.Ala558Thr missense_variant 12/14 ENST00000311014.11 NP_075462.3 Q9GZS0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DNAI2ENST00000311014.11 linkuse as main transcriptc.1672G>A p.Ala558Thr missense_variant 12/141 NM_023036.6 ENSP00000308312.6 Q9GZS0-1

Frequencies

GnomAD3 genomes
AF:
0.782
AC:
118272
AN:
151280
Hom.:
48707
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.491
Gnomad AMI
AF:
0.881
Gnomad AMR
AF:
0.883
Gnomad ASJ
AF:
0.889
Gnomad EAS
AF:
0.842
Gnomad SAS
AF:
0.826
Gnomad FIN
AF:
0.879
Gnomad MID
AF:
0.823
Gnomad NFE
AF:
0.905
Gnomad OTH
AF:
0.799
GnomAD3 exomes
AF:
0.864
AC:
213610
AN:
247294
Hom.:
93698
AF XY:
0.868
AC XY:
116358
AN XY:
134096
show subpopulations
Gnomad AFR exome
AF:
0.472
Gnomad AMR exome
AF:
0.933
Gnomad ASJ exome
AF:
0.881
Gnomad EAS exome
AF:
0.848
Gnomad SAS exome
AF:
0.831
Gnomad FIN exome
AF:
0.886
Gnomad NFE exome
AF:
0.903
Gnomad OTH exome
AF:
0.878
GnomAD4 exome
AF:
0.892
AC:
1300812
AN:
1459080
Hom.:
582883
Cov.:
70
AF XY:
0.891
AC XY:
646683
AN XY:
725786
show subpopulations
Gnomad4 AFR exome
AF:
0.481
Gnomad4 AMR exome
AF:
0.927
Gnomad4 ASJ exome
AF:
0.884
Gnomad4 EAS exome
AF:
0.850
Gnomad4 SAS exome
AF:
0.832
Gnomad4 FIN exome
AF:
0.891
Gnomad4 NFE exome
AF:
0.910
Gnomad4 OTH exome
AF:
0.863
GnomAD4 genome
AF:
0.781
AC:
118299
AN:
151398
Hom.:
48710
Cov.:
27
AF XY:
0.784
AC XY:
57965
AN XY:
73930
show subpopulations
Gnomad4 AFR
AF:
0.490
Gnomad4 AMR
AF:
0.883
Gnomad4 ASJ
AF:
0.889
Gnomad4 EAS
AF:
0.842
Gnomad4 SAS
AF:
0.826
Gnomad4 FIN
AF:
0.879
Gnomad4 NFE
AF:
0.905
Gnomad4 OTH
AF:
0.798
Alfa
AF:
0.879
Hom.:
122451
Bravo
AF:
0.769
TwinsUK
AF:
0.912
AC:
3381
ALSPAC
AF:
0.919
AC:
3543
ESP6500AA
AF:
0.497
AC:
2189
ESP6500EA
AF:
0.910
AC:
7829
ExAC
AF:
0.852
AC:
103350
Asia WGS
AF:
0.808
AC:
2808
AN:
3478
EpiCase
AF:
0.902
EpiControl
AF:
0.904

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Ala558Thr in exon 12 of DNAI2: This variant is not expected to have clinical sig nificance because it has been identified in 49.7% (2189/4406) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs1979370). -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 20, 2016- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Primary ciliary dyskinesia 9 Benign:3
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Primary ciliary dyskinesia Benign:3
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 01, 2014This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 10, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.0040
DANN
Benign
0.84
DEOGEN2
Benign
0.011
.;T;T;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.030
N
LIST_S2
Benign
0.27
T;.;T;T
MetaRNN
Benign
6.4e-7
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.64
.;N;N;.
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.3
.;N;N;.
REVEL
Benign
0.076
Sift
Benign
0.45
.;T;T;.
Sift4G
Benign
0.60
T;T;T;T
Polyphen
0.0020
.;B;B;.
Vest4
0.050
MPC
0.23
ClinPred
0.027
T
GERP RS
-9.4
Varity_R
0.027
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1979370; hg19: chr17-72308319; COSMIC: COSV56758937; COSMIC: COSV56758937; API